CTKB Q1 2023 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$37M+5.8% YoY

Gross Profit

$21M56.7% margin

Operating Income

-$12M-32.8% margin

Net Income

-$7M-18.4% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-23.3%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$2M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$525M

Total Liabilities

$101M

Stockholders' Equity

$423M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$35M	+5.8%
Gross Profit	$21M	$20M	+4.3%
Operating Income	-$12M	-$2M	-416.0%
Net Income	-$7M	-$2M	-236.8%

Revenue Segments

Product

$31M84%

Service

$6M16%

Geographic Segments

UNITED STATES

$20M53%

EMEA

$10M27%

Asia Pacific

$6M17%

Other

$996,0003%